Frailty is independently associated with 1-year mortality for elderly patients with non-ST-segment elevation myocardial infarction

Abstract

Background

For the large population of elderly patients with cardiovascular disease, it is crucial to identify clinically relevant measures of biological age and their contribution to risk. Frailty is denoting decreased physiological reserves and increased vulnerability. We analysed the manner in which the variable frailty is associated with 1-year outcomes for elderly non-ST-segment elevation myocardial infarction (NSTEMI) patients.

Methods and Results

Patients aged 75 years or older, with diagnosed NSTEMI were included at three centres, and clinical data including judgment of frailty were collected prospectively. Frailty was defined according to the Canadian Study of Health and Aging Clinical Frailty Scale. Of 307 patients, 149 (48.5%) were considered frail. By Cox regression analyses, frailty was found to be independently associated with 1-year mortality after adjusting for cardiovascular risk and comorbid conditions (hazard ratio 4.3, 95% CI 2.4–7.8). The time to the first event was significantly shorter for frail patients than for nonfrail (34 days, 95% CI 10–58, p = 0.005).

Conclusions

Frailty is strongly and independently associated with 1-year mortality. The combined use of frailty and comorbidity may constitute an important risk prediction concept in regard to cardiovascular patients with complex needs.

Keywords

Elderly frailty mortality myocardial infarction

Get full access to this article

View all access options for this article.

References

Ekerstad

Edberg

Carlsson

. Characteristics of multiple-diseased elderly in Swedish hospital care and clinical guidelines: do they make evidence-based priority setting a ‘mission impossible’? Int J Ageing Later Life 2009; 3: 71–95.

The Swedish National Board of Health and Welfare. Patienter i specialiserad vård 2007: report 2009 [in Swedish], Stockholm, Sweden: National Board of Health and Welfare, 2009.

American Heart Association Council. Acute coronary care in the elderly, part 1. Circulation 2007; 115: 2549–2569.

Metha

Cannon

Fox

. Routine vs selective invasive strategies in patients with acute coronary. JAMA 2005; 293: 2908–2917.

Hoenig

Doust

Aroney

. Early invasive versus conservative strategies for unstable angina and non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 2006; (3): CD004815–CD004815.

Tinetti

Bogardus

Jr Agostini

. Potential pitfalls of diseasespecific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870–2874.

Rothwell

. External validity of randomised controlled trials: ‘to whom do the results of this trial apply’? Lancet 2005; 365: 82–93.

Fortin

Dionne

Pinho

. Randomized clinical trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med 2006; 4: 104–108.

Lichtman

Spertus

Reid

. Acute noncardiac conditions and in-hospital mortality in patients with acute myocardial infarction. Circulation 2007; 116: 1925–1930.

10.

Singh

Rihal

Roger

. Comorbid conditions and outcomes after percutaneous coronary intervention. Heart 2008; 94: 1424–1428.

11.

Fitchett D and Rockwood K. Introduction: heart disease in an elderly population. Paper presented atthe Canadian Cardiovascular Society Consensus Conference; 26–30 October 2002; Toronto, Ontario, Canada.

12.

National Institute for Health and Clinical Excellence. Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction, CG94, London: NICE, 2010.

13.

Boyd

Darer

Boult

. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716–724.

14.

Smith

Williams

. Discussing overall prognosis with the very elderly. N Eng J Med 2011; 365: 2149–2151.

15.

National Board of Health and Welfare. The Swedish National Board of Health and Welfare’s guidelines for the care of heart disease 2008 [in Swedish]. Available at: www.socialstyrelsen.se (consulted October 2010).

16.

Mitnitski

Graham

Mogilner

. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr 2002; 2: 1–1.

17.

Rockwood

Song

MacKnight

. A global clinical measure of fitness and frailty in elderly people. Can Med Ass J 2005; 173: 489–495.

18.

Rockwood

Mitnitski

Song

. Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc 2006; 54: 975–979.

19.

Fried

Tangen

Walston

. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: 146–156.

20.

Hubbard

O’Mahony

Woodhouse

. Characterising frailty in the clinical setting: a comparison of different approaches. Age Ageing 2009; 38: 115–119.

21.

Abellan van Kan

Rolland

Houles

. The assessment of frailty in older adults. Clin Geriatr Med 2010; 26: 275–286.

22.

Sternberg

Wershof Schwartz

Karunananthan

. The identification of frailty: a systematic literature review. J Am Geriatr Soc 2011; 59: 2129–2138.

23.

Singh

Alexander

Roger

. Frailty and its potential relevance to cardiovascular care. Mayo Clin Proc 2008; 83: 1146–1153.

24.

Lee

Buth

Martin

B-J

. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac care. Circulation 2010; 121: 973–978.

25.

Murad

Kitzman

. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Heart Fail Rev 2012; 17: 581–588.

26.

Singh

Rihal

Lennon

. Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization. Circ Cardiovasc Qual Outcomes 2011; 4: 496–502.

27.

Afilalo

. Frailty in patients with cardiovascular disease: why, when, and how to measure. Curr Cardiovasc Risk Rep 2011; 5: 467–472.

28.

Myers V, Drory Y and Gerber Y. Clinical relevance of frailty trajectory post myocardial infarction. Eur J Prev Cardiol 2012 (Epub ahead of print).

29.

Sachdev

Sun

Tsiatis

. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol 2004; 43: 576–582.

30.

Ekerstad

Swahn

Janzon

. 2011. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 2011; 124: 2397–2404.

31.

Shrout

Fleiss

. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420–428.

32.

Burdock

Fleiss

Hardesty

. A new view of interobserver agreement. Personnel Psychol 1963; 16: 373–384.

33.

Lagerqvist

Husted

Kontny

. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 2006; 368: 998–1004.

34.

Kastrati

Neumann

Mehilli

. ISAR-REACT 3 Trial Investigators. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 2008; 359: 688–696.

35.

The Swedish National Board of Health and Welfare. Swedish national guidelines for stroke care 2005. Available at: www.socialstyrelsen.se/Lists/.../9092/2007-114-59_200711459.pdf (consulted February 2009).

36.

Thygesen

Alpert

White

. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007; 116: 2634–2653.

37.

Cox

. Regression models and life-tables. J Royal Stat Soc B 1972; 34: 187–220.

38.

Allison

. Logistic regression using the SAS system: theory and application, Cary, NC: Wiley SAS, 2001.

39.

Purser

Kuchibhatla

Fillenbaum

. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc 2006; 54: 1674–1681.

40.

Fried

Ferrucci

Darer

. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59: 255–263.

41.

Levey

Eckardt

Tsukamoto

. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089–2100.